CompaniesINEX Pharmaceuticals

INEX Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

29

By Phase

PHASE2: 2

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Today
NCT00006383
NCT00038207
Hover over trial bars to see details

Recent Trials

NCT00006383Lead Sponsor
Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
PHASE2Completed
Started: Jun 30, 2000 · Completed: Aug 31, 2009
NCT00038207Collaborator
Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies
PHASE2Completed
29 participants
Started: Jun 30, 2000 · Completed: Sep 30, 2005